Canada Veterinary Dermatology Drugs Market Size & Outlook, 2025-2033
Canada Veterinary Dermatology Drugs Market Insights
- According to Reed Intelligence analysis, the Canada Veterinary Dermatology Drugs Market size was USD 605.22 Million in 2024 and is projected to reach USD 1395.83 Million by 2033.
- The Canada market is projected to grow at a CAGR of 9.63% between 2025 and 2033.
- By segment, Non-steroidal anti-inflammatory drugs (NSAIDS) emerged as the largest By Drug in terms of market size in 2024.
- Non-steroidal anti-inflammatory drugs (NSAIDS) is anticipated to remain the most attractive By Drug segment, recording the fastest growth during the forecast period.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2024, Canada held 6.28% of the global Veterinary Dermatology Drugs Market size.
- By 2033, United States is anticipated to capture the largest share of the global Veterinary Dermatology Drugs Market.
- In North America, United States is expected to lead the regional Veterinary Dermatology Drugs Market size by 2033.
- United States will remain the fastest-growing market in North America, reaching USD 5392.07 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 605.22 Million |
| Market Size In 2033 | USD 1395.83 Million |
| Largest segment | Non-steroidal anti-inflammatory drugs (NSAIDS) |
| Units | Revenue in USD Million |
| CAGR | 9.63% (2025-2033) |
| Segmnetation Covered | |
| By Drug |
|
| By Animal Type |
|
| By End Users |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Canada Veterinary Dermatology Drugs Market By Drug 2025-2033 (USD Million)
| By Drug | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-steroidal anti-inflammatory drugs (NSAIDS) | XX.x | XX.x | XX.x | 317.86 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Antibiotics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Veterinary antifungal drug | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Canada Veterinary Dermatology Drugs Market By Animal Type 2025-2033 (USD Million)
| By Animal Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Large animals | XX.x | XX.x | XX.x | 391.99 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Small animals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Canada Veterinary Dermatology Drugs Market By End Users 2025-2033 (USD Million)
| By End Users | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veterinary Hospitals | XX.x | XX.x | XX.x | 340.85 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Veterinary Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
